{"id":47037,"date":"2025-11-12T21:59:41","date_gmt":"2025-11-12T13:59:41","guid":{"rendered":"https:\/\/flcube.com\/?p=47037"},"modified":"2025-11-12T21:59:42","modified_gmt":"2025-11-12T13:59:42","slug":"shandong-buchangs-luzhou-unit-moves-to-secure-exclusive-distribution-of-epo%e2%80%91igg-fusion-in-vietnam","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=47037","title":{"rendered":"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam"},"content":{"rendered":"\n<p><strong>Shandong Buchang Pharmaceuticals Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/603858:SHA\">SHA: 603858<\/a>) announced today that its subsidiary <strong>Luzhou\u202fBuchang<\/strong> will enter into an exclusive supply arrangement with <strong>Helios Pharmaceutical Company Limited<\/strong> of Vietnam and <strong>ZaoAn International Trading Co., Ltd.<\/strong>. The agreement designates Helios as the sole distributor and ZaoAn International as the intermediary for the product <strong>Efparepoetin alfa Injection<\/strong> throughout Vietnam.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-key-agreement-elements\">Key Agreement Elements<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Exclusive Distribution<\/strong> \u2013 Helios will manage registration, clinical trial coordination, marketing, and sales of Efparepoetin alfa in Vietnam.<\/li>\n\n\n\n<li><strong>Intermediary Role<\/strong> \u2013 ZaoAn International will handle regulatory filings, logistics, and trade facilitation.<\/li>\n\n\n\n<li><strong>Scope of the Product<\/strong> \u2013 The recombinant fusion protein (human EPO + human IgG2 Fc) treats anemia in adult dialysis patients with chronic kidney disease (CKD).<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-market-significance\">Market Significance<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>First\u2011In\u2011Class<\/strong> \u2013 Efparepoetin alfa is a Class\u202f1 biologic, and it is the only product of its kind approved for CKD\u2011related anemia in China.<\/li>\n\n\n\n<li><strong>Regulatory Momentum<\/strong> \u2013 The product has already submitted a marketing authorization application in China, positioning it for a swift launch in Vietnam once local approvals are secured.<\/li>\n\n\n\n<li><strong>Strategic Expansion<\/strong> \u2013 The partnership opens a new growth channel for Shandong Buchang in Southeast Asia, leveraging Helios\u2019s distribution network and ZaoAn International\u2019s trade expertise.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>Statements herein that are not historically material facts are forward\u2011looking and are based on current expectations. These involve risks and uncertainties that may cause actual results to differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today that its subsidiary Luzhou\u202fBuchang will enter&#8230;<\/p>\n","protected":false},"author":1,"featured_media":47052,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[280,4453,1103],"class_list":["post-47037","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-buchang-pharmaceuticals","tag-helios-pharmaceutical","tag-sha-603858"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today that its subsidiary Luzhou\u202fBuchang will enter into an exclusive supply arrangement with Helios Pharmaceutical Company Limited of Vietnam and ZaoAn International Trading Co., Ltd.. The agreement designates Helios as the sole distributor and ZaoAn International as the intermediary for the product Efparepoetin alfa Injection throughout Vietnam.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=47037\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam\" \/>\n<meta property=\"og:description\" content=\"Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today that its subsidiary Luzhou\u202fBuchang will enter into an exclusive supply arrangement with Helios Pharmaceutical Company Limited of Vietnam and ZaoAn International Trading Co., Ltd.. The agreement designates Helios as the sole distributor and ZaoAn International as the intermediary for the product Efparepoetin alfa Injection throughout Vietnam.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=47037\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-12T13:59:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-12T13:59:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1201-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam\",\"datePublished\":\"2025-11-12T13:59:41+00:00\",\"dateModified\":\"2025-11-12T13:59:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037\"},\"wordCount\":243,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1201-1.webp\",\"keywords\":[\"Buchang Pharmaceuticals\",\"Helios Pharmaceutical\",\"SHA: 603858\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=47037#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=47037\",\"name\":\"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1201-1.webp\",\"datePublished\":\"2025-11-12T13:59:41+00:00\",\"dateModified\":\"2025-11-12T13:59:42+00:00\",\"description\":\"Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today that its subsidiary Luzhou\u202fBuchang will enter into an exclusive supply arrangement with Helios Pharmaceutical Company Limited of Vietnam and ZaoAn International Trading Co., Ltd.. The agreement designates Helios as the sole distributor and ZaoAn International as the intermediary for the product Efparepoetin alfa Injection throughout Vietnam.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=47037\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1201-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1201-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47037#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam - Insight, China&#039;s Pharmaceutical Industry","description":"Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today that its subsidiary Luzhou\u202fBuchang will enter into an exclusive supply arrangement with Helios Pharmaceutical Company Limited of Vietnam and ZaoAn International Trading Co., Ltd.. The agreement designates Helios as the sole distributor and ZaoAn International as the intermediary for the product Efparepoetin alfa Injection throughout Vietnam.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=47037","og_locale":"en_US","og_type":"article","og_title":"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam","og_description":"Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today that its subsidiary Luzhou\u202fBuchang will enter into an exclusive supply arrangement with Helios Pharmaceutical Company Limited of Vietnam and ZaoAn International Trading Co., Ltd.. The agreement designates Helios as the sole distributor and ZaoAn International as the intermediary for the product Efparepoetin alfa Injection throughout Vietnam.","og_url":"https:\/\/flcube.com\/?p=47037","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-12T13:59:41+00:00","article_modified_time":"2025-11-12T13:59:42+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1201-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=47037#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=47037"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam","datePublished":"2025-11-12T13:59:41+00:00","dateModified":"2025-11-12T13:59:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=47037"},"wordCount":243,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=47037#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1201-1.webp","keywords":["Buchang Pharmaceuticals","Helios Pharmaceutical","SHA: 603858"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=47037#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=47037","url":"https:\/\/flcube.com\/?p=47037","name":"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=47037#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=47037#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1201-1.webp","datePublished":"2025-11-12T13:59:41+00:00","dateModified":"2025-11-12T13:59:42+00:00","description":"Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today that its subsidiary Luzhou\u202fBuchang will enter into an exclusive supply arrangement with Helios Pharmaceutical Company Limited of Vietnam and ZaoAn International Trading Co., Ltd.. The agreement designates Helios as the sole distributor and ZaoAn International as the intermediary for the product Efparepoetin alfa Injection throughout Vietnam.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=47037#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=47037"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=47037#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1201-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1201-1.webp","width":1080,"height":608,"caption":"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=47037#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shandong Buchang\u2019s Luzhou Unit Moves to Secure Exclusive Distribution of Epo\u2011IgG Fusion in Vietnam"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1201-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=47037"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47037\/revisions"}],"predecessor-version":[{"id":47053,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47037\/revisions\/47053"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/47052"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=47037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=47037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=47037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}